These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3371837)

  • 21. Serum digoxin levels related to plasma propafenone levels during concomitant treatment.
    Bigot MC; Debruyne D; Bonnefoy L; Grollier G; Moulin M; Potier JC
    J Clin Pharmacol; 1991 Jun; 31(6):521-6. PubMed ID: 1880217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of troglitazone on steady-state pharmacokinetics of digoxin.
    Loi CM; Knowlton PW; Stern R; Randinitis EJ; Vassos AB; Koup JR; Sedman AJ
    J Clin Pharmacol; 1998 Feb; 38(2):178-83. PubMed ID: 9549650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum digoxin levels using an 125I-labelled antigen: Validation of method and observations on cardiac patients.
    Taubert K; Shapiro W
    Am Heart J; 1975 Jan; 89(1):79-86. PubMed ID: 1109556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of in vitro data in making accurate predictions of human P-glycoprotein-mediated drug-drug interactions: a case study for AZD5672.
    Elsby R; Gillen M; Butters C; Imisson G; Sharma P; Smith V; Surry DD
    Drug Metab Dispos; 2011 Feb; 39(2):275-82. PubMed ID: 21075975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digoxin-trimethoprim interaction.
    Petersen P; Kastrup J; Bartram R; Mølholm Hansen J
    Acta Med Scand; 1985; 217(4):423-7. PubMed ID: 4013832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of quinidine on plasma concentration and renal clearance of digoxin. A clinically important drug interaction.
    Dahlqvist R; Ejvinsson G; Schenck-Gustafsson K
    Br J Clin Pharmacol; 1980 Apr; 9(4):413-8. PubMed ID: 7378258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of oral spironolactone and intravenous canrenoate-K on the digoxin radioimmunoassay.
    Lichey J; Schröder R; Rietbrock N
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):557-9. PubMed ID: 598949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of possible interaction between pinaverium bromide and digoxin.
    Weitzel O; Seidel G; Engelbert S; Berksoy M; Eberhardt G; Bode R
    Curr Med Res Opin; 1983; 8(8):600-2. PubMed ID: 6653138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal assessment of a P-glycoprotein-mediated drug interaction of valspodar on digoxin.
    Kovarik JM; Rigaudy L; Guerret M; Gerbeau C; Rost KL
    Clin Pharmacol Ther; 1999 Oct; 66(4):391-400. PubMed ID: 10546923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, with coadministration of digoxin.
    Stangier J; Stähle H; Rathgen K; Roth W; Reseski K; Körnicke T
    J Clin Pharmacol; 2012 Feb; 52(2):243-50. PubMed ID: 21868715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance digoxin dosage and steady-state plasma concentration in infants and children.
    Hastreiter AR; van der Horst RL; Voda C; Chow-Tung E
    J Pediatr; 1985 Jul; 107(1):140-6. PubMed ID: 4009331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants.
    Devineni D; Manitpisitkul P; Vaccaro N; Bernard A; Skee D; Mamidi RN; Tian H; Weiner S; Stieltjes H; Sha S; Rothenberg P
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):41-53. PubMed ID: 25345427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease.
    Taylor A; Beerahee A; Citerone D; Davy M; Fitzpatrick K; Lopez-Gil A; Stocchi F
    Br J Clin Pharmacol; 1999 Feb; 47(2):219-22. PubMed ID: 10190658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digoxin-quinidine interaction in the dog.
    De Rick A; Belpaire F
    J Vet Pharmacol Ther; 1981 Sep; 4(3):215-8. PubMed ID: 7349336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combination of oral administration of cibenzoline and digoxin in patients with supraventricular arrhythmia].
    Garnier LF; Bine-Scheck F; Pruvost P; Wanszelbaum H; Arnaud R
    Ann Cardiol Angeiol (Paris); 1992 Sep; 41(7):411-7. PubMed ID: 1285630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digoxin-rifampin interaction.
    Gault H; Longerich L; Dawe M; Fine A
    Clin Pharmacol Ther; 1984 Jun; 35(6):750-4. PubMed ID: 6734026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of the digoxin concentration in the blood plasma of patients with cardiopulmonary failure].
    Sidorova LD; Arkhipova GF; Kudelia LM; Pavlova IP
    Farmakol Toksikol; 1986; 49(5):22-5. PubMed ID: 3770167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma digoxin concentrations in patients with atrial fibrillation.
    Chamberlain DA; White RJ; Howard MR; Smith TW
    Br Med J; 1970 Aug; 3(5720):429-32. PubMed ID: 5454321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between digoxin and the calcium antagonists nicardipine and tiapamil.
    Lessem J; Bellinetto A
    Clin Ther; 1983; 5(6):595-602. PubMed ID: 6627286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of antacids on plasma concentration of digoxin in man (author's transl)].
    Vöhringer HF; Kuhlmann J; Rietbrock N
    Dtsch Med Wochenschr; 1976 Jan; 101(4):106-8. PubMed ID: 1245165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.